欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FI/H/0865/001
药品名称
Canesten 500 mg
活性成分
clotrimazole 500.0 mg
剂型
Vaginal capsule, soft
上市许可持有人
Bayer Oy Pansiontie 47 20101 Turku Finland
参考成员国 - 产品名称
Finland (FI)
互认成员国 - 产品名称
Slovenia (SI)
Slovakia (SK)
Czechia (CZ)
Canesten Gyn
Croatia (HR)
Canesten 1 500 mg meka kapsula za rodnicu
Austria (AT)
Canesten Clotrimazol 0,5 g Weichkapsel zur vaginalen Anwendung
Italy (IT)
Poland (PL)
Canesten
Latvia (LV)
Canesten 500 mg vaginālā mīkstā kapsula
Lithuania (LT)
Canesten 500 mg makšties minkštoji kapsulė
Estonia (EE)
CANESTEN
Bulgaria (BG)
Canesten
Romania (RO)
许可日期
2016/09/14
最近更新日期
2024/08/05
药物ATC编码
G01AF02 clotrimazole
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Non Prescription (including OTC)
附件文件下载
Final PL
|
Canesten FI_H_865_01_DC final PL
Date of last change:2024/09/06
Final SPC
|
Canesten FI_H_865_01_DC final SPC
Date of last change:2024/09/06
PubAR
|
FI_H_865_01_DC Canesten Public AR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase